We've updated our Privacy Policy to make it clearer how we use your personal data.
We use cookies to provide you with a better experience, read our Cookie Policy
Bruker Daltonics Scientific Posters
Innovations such as Trapped Ion Mobility (TIMS), smartbeam and scanning lasers for MALDI-MS Imaging that deliver true pixel fidelity, and eXtreme Resolution FTMS (XR) technology capable to reveal Isotopic Fine Structure (IFS) signatures are pushing scientific exploration to new heights. Our mass spectrometry solutions enable scientists to make breakthrough discoveries and gain deeper insights.
Bruker's product lines include the following technologies: timsTOF, MRMS, rapifleX® MALDI-TOF/TOF, UHR-QTOF, Triple Quadrupole, HDX Solution, Toxtyper® and TargetScreener HR. Our industry leading software solutions such as SCiLS™ Lab for MS Imaging, MetaboScape® and Biopharma Compass® are examples for our solutions doing the work for you.
For Research Use Only
Not for Use in Clinical Diagnostic Procedures
Stuart Pengelley1, Eckhard Belau1, Waltraud Evers1, Christina Bell1, Michael Greig2, Detlev Suckau1
1Bruker Daltonics GmbH & Co. KG, Bremen, Germany 2Bruker Scientific LLC, San Jose, USA
Xuejun Peng 1 , Eric S.E. van Beelen 2 , Ismael Zamora 3 , Anjali Alving 1 ,
1 Bruker Scientific LLC, Billerica, MA, USA 2 Bruker Daltonics GmbH & Co. KG, Bremen, Germany ; 3Lead Molecular Design, Barcelona Spain
Yue Ju 1 , Guillaume Tremintin 1 , Aditya Kulkarni 2
1 Bruker Scientific LLC., San Jose, CA, US 2 908 Devices, Boston, MA, US
Aiko Barsch1; Matthias Szesny1; Ulrike Schweiger-Hufnagel1; Sofie Weinkouff1, Nikolas Kessler1
1Bruker Daltonics GmbH & Co. KG Bremen, Germany
Jörg Büscher 1 , Sofie Weinkouff 2 , Ansgar Korf 2 , Aiko Barsch 2 , Nikolas Kessler 2
1 Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany 2 Bruker Daltonics GmbH & Co. KG, 28359 Bremen, Germany
Melvin Gay1; Aude-Claire Morillon2; Sven Myers3; Magdalene Reinkensmeier3; Aiko Barsch3; Nicola Gray2; Berin Boughton2; Nathan Lawler2; Jeremy Nicholson2,4; Luke Whiley2
1 Bruker Pty Ltd, Victoria, Australia 2 Australian National Phenome Centre, Health Futures Institute, Murdoch University, Australia 3 Bruker Daltonics GmbH & Co. KG Bremen, Germany 4 Institute of Global Health Innovation, Imperial College London, UK
Ansgar Korf 3 , Nikolas Kessler 3 , Heiko Neuweger 3 , Sven W. Meyer 3 , Yorrick R.J. Jaspers 1 , Michel van Weeghel 1,2 , Frédéric M. Vaz 1,2
1 Bruker Daltonics GmbH & Co. KG, Bremen, Germany 2 Laboratory Genetic Metabolic Diseases, Amsterdam UMC, the Netherlands 3 Core Facility Metabolomics, Amsterdam UMC, the Netherlands
Emanuela Salviati 1 , Eduardo Sommella 1 , Giulio Verna 1 , Aiko Barsch 2 , Matthias Witt 2 , Jochen Friedrich 2 Pietro Campiglia 1
1 University of Salerno, Department of Pharmacy, Fisciano , Italy; 2 Bruker Daltonics GmbH & Co. KG, Bremen, Germany
Sofie Weinkouff 1 , Joerg M. Buescher 2 , Aiko Barsch 1 , Nikolas Kessler 1
1 Bruker Daltonics GmbH & Co. KG, Bremen, Germany 2 Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
Eduardo Sommella, 1 Fabrizio Merciai, 1 Albino Carrizzo, 2 Carmine Vecchione, 2 Pietro Campiglia, 1 Heiko Neuweger 3
1 University of Salerno, Department of Pharmacy, Fisciano (SA), Italy 2 University of Salerno, Department of Medicine and Surgery, Baronissi (SA), Italy 3 Bruker Daltonics GmbH & Co. KG., Bremen, Germany
Ulrike Resch 1 , Goran Mitulović 2
1 Dept. Vasc . Biol. Thromb . Res., CPP, Medical University of Vienna, Austria ; 2 Bruker Austria, Vienna, Austria
Corinna Henkel1, Signe Frost Frederiksen, Nagarjuna Nagaraj1, Sven Meyer1, Tobias Boskamp1, Janine Beckmann2, Janina Oetjen1, Dennis Jakob2, Michael L. Easterling3
1. Bruker Daltonics GmbH & Co. KG, Bremen, Germany; 2. Max Planck Institute for Marine Microbiology, Bremen, Germany; 3. Bruker Daltonics Inc., Billerica, MA, USA
1Janina Oetjen, 1Arne Fuetterer, 1Christian Tabeling, 1Arne Brix, 2Michael Easterling.
1. Bruker Daltonics GmbH & Co. KG, Bremen, Germany. 2. Bruker Daltonics Inc., Billerica, MA, USA
Matthias Witt, 1 Yongwei Wang 2 Michael Greig, 3 Jia Liu, 4 Changqiang Ke 4 and Yang Ye 4
1 Bruker Daltonics GmbH & Co. KG, Bremen, Germany 2 Bruker Daltonics Corporation, Shanghai, China 3 Bruker Daltonics Inc, Billerica, MA, USA 4 Shanghai Institute of Materia Medica, CAS
Matthias Witt 1 Cameron Heaton, 2 Katie Kennedy, 2 Glenn Langenburg, 3 Simona Francese, 2
1 Bruker Daltonics GmbH & Co. KG, Bremen, Germany 2 Sheffield Hallam University, Sheffield, UK 3 Bruker Elite Forensic Services, Saint Paul, MN, US
Jeremy Foster,1 Christopher Taron, 1 and Katherine A. Stumpo 2,3,4
1New England Biolabs, Ipswich, MA; 2Bruker Daltonics, Billerica, MA; 3The Johns Hopkins University School of Medicine, Russell H. Morgan Department of Radiology and Radiological Science, Baltimore, MD; 4Department of Chemistry, University of Scranton, Scranton, PA
Website: http://www.bruker.com/daltonics
Email: ms.sales.bdal@bruker.com
Telephone:978-663-3660